Discontinuation report ACCOLATE TAB 20 MG
| Report ID | 19358 |
| Drug Identification Number | 02236606 |
| Brand name | ACCOLATE TAB 20 MG |
| Common or Proper name | zafirlukast tablets |
| Company Name | ASTRAZENECA CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ZAFIRLUKAST |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 60 |
| ATC code | R03DC |
| ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2017-12-31 |
| Actual discontinuation date | 2018-01-02 |
| Remaining supply date | 2017-12-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2018-01-08 | French | Compare |
| v3 | 2018-01-08 | English | Compare |
| v2 | 2017-08-15 | French | Compare |
| v1 | 2017-08-15 | English | Compare |
Showing 1 to 4 of 4